O10 Normalisation of calprotectin within 12-months of diagnosis is associated with reduced disease progression in crohns

Autor:	Nikolas Plevris, Philip Jenkinson, Ian D. Arnott, James Fulforth, Spyros I. Siakavellas, Gareth T. Jones, Mathew Lyons, Charlie W. Lees, Rebecca J Pattenden
Rok vydání:	2021
Předmět:	medicine.medical_specialty business.industry Internal medicine Disease progression Medicine Calprotectin business Gastroenterology
Zdroj:	Oral.
DOI:	10.1136/gutjnl-2020-bsgcampus.10
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7ed4d4a59160a7d38399c59f857e5a1d https://doi.org/10.1136/gutjnl-2020-bsgcampus.10 Zobrazit plný text záznamu